article · Medical Journal of Zambia
Dear Editor, We write to bring to attention, a critical matter in public health and infectious diseases research - the advent, implementation, and utilization of Long-ActingAntiretroviralTherapy(LA-ART)injectables, specifically Cabotegravir–Rilpivirine (CAB/RPV), in the context of Africa and the developing regions of the world by extension.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.55320/mjz.52.1.625
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
